O35516

SS
Gene name
Notch2
Protein name
Neurogenic locus notch homolog protein 2
Names
Notch 2, Motch B
Species
Mus musculus (Mouse)
KEGG Pathway
mmu:18129
EC number
Protein Class

Descriptions

NOTCH2 is a neurogenic locus notch homolog protein 2 and belongs to NOTCH family of proteins that regulate cell growth, proliferation, differentiation and apoptosis in both embryonic and adult tissues. The negative regulatory region (NRR) of NOTCH2 contains three Lin12/Notch repeats (LNR-A, LNR-B, and LNR-C). The LNR-C hydrophobic residues pack against the heterodimerization (HD) domain core. In addition, the LNR-B, the linker between LNR-A and LNR-B, and the C-terminus of LNR-A wrap around the HD domain, thus masking the metalloprotease site (S2) and preventing exposure to receptor activation. For the activation of NOTCH2, the LNR-A, LNR-AB linker, and LNR-B must be removed.

Autoinhibitory domains (AIDs)

1425-1544 (LNR-A, B, and C) SS

Target domain

1539-1677 (HD domain)

Relief mechanism

Cleavage

Assay

Accessory elements

No accessory elements

References

Autoinhibited structure

Activated structure

1 structures for O35516

Entry ID Method Resolution Chain Position Source
AF-O35516-F1 Predicted AlphaFoldDB

18 variants for O35516

Variant ID(s) Position Change Description Diseaes Association Provenance
rs37314952 136 G>S No Ensembl
rs226918520 166 F>L No Ensembl
rs257935465 166 F>V No Ensembl
rs243857278 169 K>T No Ensembl
rs213628653 178 K>R No Ensembl
rs233360132 189 P>L No Ensembl
rs36672347 255 S>N No Ensembl
rs241051300 655 M>I No Ensembl
rs255821861 680 N>S No Ensembl
rs37923132 1015 V>M No Ensembl
rs231132983 1037 A>S No Ensembl
rs212468817 1069 R>W No Ensembl
rs864297508 1388 T>S No Ensembl
rs864260195 1388 T>S No Ensembl
rs226095566 1469 T>S No Ensembl
rs1132158694 1980 S>F No Ensembl
rs37468219 1996 L>V No Ensembl
rs38262459 2348 P>A No Ensembl

No associated diseases with O35516

110 regional properties for O35516

Type Name Position InterPro Accession
ptm EGF-type aspartate/asparagine hydroxylation site 198 - 209 IPR000152-1
ptm EGF-type aspartate/asparagine hydroxylation site 275 - 286 IPR000152-2
ptm EGF-type aspartate/asparagine hydroxylation site 315 - 326 IPR000152-3
ptm EGF-type aspartate/asparagine hydroxylation site 353 - 364 IPR000152-4
ptm EGF-type aspartate/asparagine hydroxylation site 433 - 444 IPR000152-5
ptm EGF-type aspartate/asparagine hydroxylation site 471 - 482 IPR000152-6
ptm EGF-type aspartate/asparagine hydroxylation site 509 - 520 IPR000152-7
ptm EGF-type aspartate/asparagine hydroxylation site 547 - 558 IPR000152-8
ptm EGF-type aspartate/asparagine hydroxylation site 584 - 595 IPR000152-9
ptm EGF-type aspartate/asparagine hydroxylation site 622 - 633 IPR000152-10
ptm EGF-type aspartate/asparagine hydroxylation site 659 - 670 IPR000152-11
ptm EGF-type aspartate/asparagine hydroxylation site 697 - 708 IPR000152-12
ptm EGF-type aspartate/asparagine hydroxylation site 772 - 783 IPR000152-13
ptm EGF-type aspartate/asparagine hydroxylation site 810 - 821 IPR000152-14
ptm EGF-type aspartate/asparagine hydroxylation site 888 - 899 IPR000152-15
ptm EGF-type aspartate/asparagine hydroxylation site 926 - 937 IPR000152-16
ptm EGF-type aspartate/asparagine hydroxylation site 964 - 975 IPR000152-17
ptm EGF-type aspartate/asparagine hydroxylation site 1002 - 1013 IPR000152-18
ptm EGF-type aspartate/asparagine hydroxylation site 1040 - 1051 IPR000152-19
ptm EGF-type aspartate/asparagine hydroxylation site 1164 - 1175 IPR000152-20
ptm EGF-type aspartate/asparagine hydroxylation site 1202 - 1213 IPR000152-21
ptm EGF-type aspartate/asparagine hydroxylation site 1241 - 1252 IPR000152-22
domain EGF-like domain 24 - 63 IPR000742-1
domain EGF-like domain 64 - 102 IPR000742-2
domain EGF-like domain 105 - 143 IPR000742-3
domain EGF-like domain 144 - 180 IPR000742-4
domain EGF-like domain 182 - 219 IPR000742-5
domain EGF-like domain 221 - 258 IPR000742-6
domain EGF-like domain 260 - 296 IPR000742-7
domain EGF-like domain 298 - 336 IPR000742-8
domain EGF-like domain 338 - 374 IPR000742-9
domain EGF-like domain 375 - 413 IPR000742-10
domain EGF-like domain 415 - 454 IPR000742-11
domain EGF-like domain 456 - 492 IPR000742-12
domain EGF-like domain 494 - 530 IPR000742-13
domain EGF-like domain 532 - 568 IPR000742-14
domain EGF-like domain 570 - 605 IPR000742-15
domain EGF-like domain 607 - 643 IPR000742-16
domain EGF-like domain 645 - 680 IPR000742-17
domain EGF-like domain 682 - 718 IPR000742-18
domain EGF-like domain 720 - 755 IPR000742-19
domain EGF-like domain 757 - 793 IPR000742-20
domain EGF-like domain 795 - 831 IPR000742-21
domain EGF-like domain 833 - 871 IPR000742-22
domain EGF-like domain 873 - 909 IPR000742-23
domain EGF-like domain 911 - 947 IPR000742-24
domain EGF-like domain 949 - 985 IPR000742-25
domain EGF-like domain 987 - 1023 IPR000742-26
domain EGF-like domain 1025 - 1061 IPR000742-27
domain EGF-like domain 1063 - 1099 IPR000742-28
domain EGF-like domain 1104 - 1147 IPR000742-29
domain EGF-like domain 1149 - 1185 IPR000742-30
domain EGF-like domain 1187 - 1223 IPR000742-31
domain EGF-like domain 1225 - 1262 IPR000742-32
domain EGF-like domain 1264 - 1302 IPR000742-33
domain EGF-like domain 1304 - 1343 IPR000742-34
domain EGF-like domain 1375 - 1412 IPR000742-35
domain Notch domain 1418 - 1544 IPR000800
domain EGF-like calcium-binding domain 64 - 102 IPR001881-1
domain EGF-like calcium-binding domain 109 - 143 IPR001881-2
domain EGF-like calcium-binding domain 146 - 180 IPR001881-3
domain EGF-like calcium-binding domain 182 - 219 IPR001881-4
domain EGF-like calcium-binding domain 225 - 258 IPR001881-5
domain EGF-like calcium-binding domain 260 - 296 IPR001881-6
domain EGF-like calcium-binding domain 298 - 336 IPR001881-7
domain EGF-like calcium-binding domain 338 - 374 IPR001881-8
domain EGF-like calcium-binding domain 377 - 413 IPR001881-9
domain EGF-like calcium-binding domain 415 - 454 IPR001881-10
domain EGF-like calcium-binding domain 456 - 492 IPR001881-11
domain EGF-like calcium-binding domain 494 - 530 IPR001881-12
domain EGF-like calcium-binding domain 532 - 568 IPR001881-13
domain EGF-like calcium-binding domain 570 - 605 IPR001881-14
domain EGF-like calcium-binding domain 607 - 643 IPR001881-15
domain EGF-like calcium-binding domain 645 - 680 IPR001881-16
domain EGF-like calcium-binding domain 682 - 718 IPR001881-17
domain EGF-like calcium-binding domain 720 - 755 IPR001881-18
domain EGF-like calcium-binding domain 757 - 793 IPR001881-19
domain EGF-like calcium-binding domain 795 - 831 IPR001881-20
domain EGF-like calcium-binding domain 837 - 871 IPR001881-21
domain EGF-like calcium-binding domain 873 - 909 IPR001881-22
domain EGF-like calcium-binding domain 911 - 947 IPR001881-23
domain EGF-like calcium-binding domain 949 - 985 IPR001881-24
domain EGF-like calcium-binding domain 987 - 1023 IPR001881-25
domain EGF-like calcium-binding domain 1025 - 1061 IPR001881-26
domain EGF-like calcium-binding domain 1064 - 1099 IPR001881-27
domain EGF-like calcium-binding domain 1105 - 1147 IPR001881-28
domain EGF-like calcium-binding domain 1149 - 1185 IPR001881-29
domain EGF-like calcium-binding domain 1187 - 1223 IPR001881-30
domain EGF-like calcium-binding domain 1225 - 1262 IPR001881-31
domain EGF-like calcium-binding domain 1264 - 1302 IPR001881-32
domain EGF-like calcium-binding domain 1306 - 1343 IPR001881-33
domain EGF-like calcium-binding domain 1373 - 1412 IPR001881-34
repeat Ankyrin repeat 1828 - 1940 IPR002110-1
repeat Ankyrin repeat 1944 - 2042 IPR002110-2
domain Notch, NOD domain 1539 - 1595 IPR010660
domain Notch, NODP domain 1619 - 1679 IPR011656
conserved_site EGF-like, conserved site 230 - 252 IPR013032-1
conserved_site EGF-like, conserved site 347 - 367 IPR013032-2
conserved_site EGF-like, conserved site 579 - 599 IPR013032-3
conserved_site EGF-like, conserved site 729 - 749 IPR013032-4
conserved_site EGF-like calcium-binding, conserved site 182 - 207 IPR018097-1
conserved_site EGF-like calcium-binding, conserved site 260 - 284 IPR018097-2
conserved_site EGF-like calcium-binding, conserved site 456 - 480 IPR018097-3
conserved_site EGF-like calcium-binding, conserved site 532 - 556 IPR018097-4
conserved_site EGF-like calcium-binding, conserved site 682 - 706 IPR018097-5
conserved_site EGF-like calcium-binding, conserved site 873 - 897 IPR018097-6
conserved_site EGF-like calcium-binding, conserved site 1025 - 1049 IPR018097-7
conserved_site EGF-like calcium-binding, conserved site 1149 - 1173 IPR018097-8
conserved_site EGF-like calcium-binding, conserved site 1225 - 1250 IPR018097-9
domain Notch, C-terminal 2382 - 2447 IPR024600

Functions

Description
EC Number
Subcellular Localization
  • [Notch 2 extracellular truncation]: Cell membrane ; Single-pass type I membrane protein
  • ;
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

10 GO annotations of cellular component

Name Definition
cell surface The external part of the cell wall and/or plasma membrane.
cilium A specialized eukaryotic organelle that consists of a filiform extrusion of the cell surface and of some cytoplasmic parts. Each cilium is largely bounded by an extrusion of the cytoplasmic (plasma) membrane, and contains a regular longitudinal array of microtubules, anchored to a basal body.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
extracellular matrix A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
extracellular region The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
receptor complex Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

4 GO annotations of molecular function

Name Definition
calcium ion binding Binding to a calcium ion (Ca2+).
enzyme binding Binding to an enzyme, a protein with catalytic activity.
NF-kappaB binding Binding to NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters.
signaling receptor activity Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.

47 GO annotations of biological process

Name Definition
animal organ morphogenesis Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
atrial septum morphogenesis The developmental process in which atrial septum is generated and organized. The atrial septum separates the upper chambers (the atria) of the heart from one another.
bone remodeling The continuous turnover of bone matrix and mineral that involves first, an increase in resorption (osteoclastic activity) and later, reactive bone formation (osteoblastic activity). The process of bone remodeling takes place in the adult skeleton at discrete foci. The process ensures the mechanical integrity of the skeleton throughout life and plays an important role in calcium homeostasis. An imbalance in the regulation of bone resorption and bone formation results in many of the metabolic bone diseases, such as osteoporosis.
cell fate determination A process involved in cell fate commitment. Once determination has taken place, a cell becomes committed to differentiate down a particular pathway regardless of its environment.
cellular response to tumor cell Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a tumor cell.
central nervous system development The process whose specific outcome is the progression of the central nervous system over time, from its formation to the mature structure. The central nervous system is the core nervous system that serves an integrating and coordinating function. In vertebrates it consists of the brain and spinal cord. In those invertebrates with a central nervous system it typically consists of a brain, cerebral ganglia and a nerve cord.
cholangiocyte proliferation The multiplication or reproduction of cholangiocytes, resulting in the expansion of the cholangiocyte population. A cholangiocyte is an epithelial cell that is part of the bile duct. Cholangiocytes contribute to bile secretion via net release of bicarbonate and water.
ciliary body morphogenesis The process in which the ciliary body generated and organized. The ciliary body is the circumferential tissue inside the eye composed of the ciliary muscle and ciliary processes.
defense response to bacterium Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism.
determination of left/right symmetry The establishment of an organism's body plan or part of an organism with respect to the left and right halves. The pattern can either be symmetric, such that the halves are mirror images, or asymmetric where the pattern deviates from this symmetry.
embryonic limb morphogenesis The process, occurring in the embryo, by which the anatomical structures of the limb are generated and organized. A limb is an appendage of an animal used for locomotion or grasping.
glomerular capillary formation The process that gives rise to a glomerular capillary. This process pertains to the initial formation of a structure from unspecified parts.
glomerular visceral epithelial cell development The process whose specific outcome is the progression of a glomerular visceral epithelial cell over time, from its formation to the mature structure. A glomerular visceral epithelial cell is a specialized epithelial cell that contains 'feet' that interdigitate with the 'feet' of other glomerular epithelial cells.
heart looping The tube morphogenesis process in which the primitive heart tube loops asymmetrically. This looping brings the primitive heart chambers into alignment preceding their future integration. Heart looping begins with dextral-looping and ends when the main regional divisions of the mature heart and primordium of the great arterial trunks become established preceeding septation.
hepatocyte proliferation The multiplication or reproduction of hepatocytes, resulting in the expansion of a cell population. Hepatocytes form the main structural component of the liver. They are specialized epithelial cells that are organized into interconnected plates called lobules.
humoral immune response An immune response mediated through a body fluid.
in utero embryonic development The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
inflammatory response to antigenic stimulus An inflammatory response to an antigenic stimulus, which can be include any number of T cell or B cell epitopes.
intrahepatic bile duct development The progression of the intrahepatic bile ducts over time, from their formation to the mature structure. Intrahepatic bile ducts (bile ducts within the liver) collect bile from bile canaliculi in the liver, and connect to the extrahepatic bile ducts (bile ducts outside the liver).
left/right axis specification The establishment, maintenance and elaboration of the left/right axis. The left/right axis is defined by a line that runs orthogonal to both the anterior/posterior and dorsal/ventral axes. Each side is defined from the viewpoint of the organism rather of the observer (as per anatomical axes).
liver development The process whose specific outcome is the progression of the liver over time, from its formation to the mature structure. The liver is an exocrine gland which secretes bile and functions in metabolism of protein and carbohydrate and fat, synthesizes substances involved in the clotting of the blood, synthesizes vitamin A, detoxifies poisonous substances, stores glycogen, and breaks down worn-out erythrocytes.
liver morphogenesis The process in which the anatomical structures of the liver are generated and organized.
marginal zone B cell differentiation The process in which a B cell in the spleen acquires the specialized features of a marginal zone B cell. Marginal zone B cells are localized in a distinct anatomical region of the spleen that represents the major antigen-filtering and scavenging area (by specialized macrophages resident there). It appears that they are preselected to express a BCR repertoire similar to B-1 B cells, biased toward bacterial cell wall constituents and senescent self-components (such as oxidized LDL).
morphogenesis of an epithelial sheet The process in which the anatomical structures of an epithelial sheet are generated and organized. An epithelial sheet is a flat surface consisting of closely packed epithelial cells.
multicellular organism growth The increase in size or mass of an entire multicellular organism, as opposed to cell growth.
myeloid dendritic cell differentiation The process in which a monocyte acquires the specialized features of a dendritic cell, an immunocompetent cell of the lymphoid and hemopoietic systems and skin.
negative regulation of gene expression Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA).
negative regulation of growth rate Any process that reduces the rate of growth of all or part of an organism.
negative regulation of transcription by RNA polymerase II Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II.
Notch signaling pathway The series of molecular signals initiated by an extracellular ligand binding to the receptor Notch on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
placenta blood vessel development The process whose specific outcome is the progression of a blood vessel of the placenta over time, from its formation to the mature structure.
placenta development The process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin.
positive regulation of apoptotic process Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
positive regulation of BMP signaling pathway Any process that activates or increases the frequency, rate or extent of BMP signaling pathway activity.
positive regulation of cell population proliferation Any process that activates or increases the rate or extent of cell proliferation.
positive regulation of ERK1 and ERK2 cascade Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
positive regulation of keratinocyte proliferation Any process that increases the rate, frequency or extent of keratinocyte proliferation. Keratinocyte proliferation is the multiplication or reproduction of keratinocytes, resulting in the expansion of a cell population.
positive regulation of osteoclast differentiation Any process that activates or increases the frequency, rate or extent of osteoclast differentiation.
positive regulation of Ras protein signal transduction Any process that activates or increases the frequency, rate or extent of Ras protein signal transduction.
proximal tubule development The process whose specific outcome is the progression of the proximal tubule over time, from its formation to the mature structure. In mammals, the proximal tubule is a nephron tubule that connects Bowman's capsule to the descending thin limb of the loop of Henle. It has a brush border epithelial morphology.
pulmonary valve morphogenesis The process in which the structure of the pulmonary valve is generated and organized.
regulation of actin cytoskeleton reorganization Any process that modulates the frequency, rate or extent of actin cytoskeleton reorganization.
regulation of cell cycle Any process that modulates the rate or extent of progression through the cell cycle.
regulation of osteoclast development Any process that modulates the frequency, rate or extent of osteoclast development.
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.
skeletal system development The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
wound healing The series of events that restore integrity to a damaged tissue, following an injury.

13 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q868Z9 Ppn Papilin Drosophila melanogaster (Fruit fly) SS
P46531 NOTCH1 Neurogenic locus notch homolog protein 1 Homo sapiens (Human) EV
P21941 MATN1 Cartilage matrix protein Homo sapiens (Human) PR
Q04721 NOTCH2 Neurogenic locus notch homolog protein 2 Homo sapiens (Human) EV
Q6GUQ1 Egfl8 Epidermal growth factor-like protein 8 Mus musculus (Mouse) PR
Q01705 Notch1 Neurogenic locus notch homolog protein 1 Mus musculus (Mouse) SS
Q91V88 Npnt Nephronectin Mus musculus (Mouse) PR
P51942 Matn1 Cartilage matrix protein Mus musculus (Mouse) PR
Q07008 Notch1 Neurogenic locus notch homolog protein 1 Rattus norvegicus (Rat) SS
Q9QW30 Notch2 Neurogenic locus notch homolog protein 2 Rattus norvegicus (Rat) SS
P13508 glp-1 Protein glp-1 Caenorhabditis elegans EV
A2RUV0 notch1 Neurogenic locus notch homolog protein 1 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) SS
P46530 notch1a Neurogenic locus notch homolog protein 1 Danio rerio (Zebrafish) (Brachydanio rerio) SS
10 20 30 40 50 60
MPALRPAALR ALLWLWLCGA GPAHALQCRG GQEPCVNEGT CVTYHNGTGF CRCPEGFLGE
70 80 90 100 110 120
YCQHRDPCEK NRCQNGGTCV PQGMLGKATC RCAPGFTGED CQYSTSHPCF VSRPCQNGGT
130 140 150 160 170 180
CHMLSRDTYE CTCQVGFTGK QCQWTDACLS HPCENGSTCT SVASQFSCKC PAGLTGQKCE
190 200 210 220 230 240
ADINECDIPG RCQHGGTCLN LPGSYRCQCP QGFTGQHCDS PYVPCAPSPC VNGGTCRQTG
250 260 270 280 290 300
DFTFECNCLP GFEGSTCERN IDDCPNHKCQ NGGVCVDGVN TYNCRCPPQW TGQFCTEDVD
310 320 330 340 350 360
ECLLQPNACQ NGGTCTNRNG GYGCVCVNGW SGDDCSENID DCAYASCTPG STCIDRVASF
370 380 390 400 410 420
SCLCPEGKAG LLCHLDDACI SNPCHKGALC DTNPLNGQYI CTCPQGYKGA DCTEDVDECA
430 440 450 460 470 480
MANSNPCEHA GKCVNTDGAF HCECLKGYAG PRCEMDINEC HSDPCQNDAT CLDKIGGFTC
490 500 510 520 530 540
LCMPGFKGVH CELEVNECQS NPCVNNGQCV DKVNRFQCLC PPGFTGPVCQ IDIDDCSSTP
550 560 570 580 590 600
CLNGAKCIDH PNGYECQCAT GFTGILCDEN IDNCDPDPCH HGQCQDGIDS YTCICNPGYM
610 620 630 640 650 660
GAICSDQIDE CYSSPCLNDG RCIDLVNGYQ CNCQPGTSGL NCEINFDDCA SNPCMHGVCV
670 680 690 700 710 720
DGINRYSCVC SPGFTGQRCN IDIDECASNP CRKGATCIND VNGFRCICPE GPHHPSCYSQ
730 740 750 760 770 780
VNECLSNPCI HGNCTGGLSG YKCLCDAGWV GVNCEVDKNE CLSNPCQNGG TCNNLVNGYR
790 800 810 820 830 840
CTCKKGFKGY NCQVNIDECA SNPCLNQGTC FDDVSGYTCH CMLPYTGKNC QTVLAPCSPN
850 860 870 880 890 900
PCENAAVCKE APNFESFSCL CAPGWQGKRC TVDVDECISK PCMNNGVCHN TQGSYVCECP
910 920 930 940 950 960
PGFSGMDCEE DINDCLANPC QNGGSCVDHV NTFSCQCHPG FIGDKCQTDM NECLSEPCKN
970 980 990 1000 1010 1020
GGTCSDYVNS YTCTCPAGFH GVHCENNIDE CTESSCFNGG TCVDGINSFS CLCPVGFTGP
1030 1040 1050 1060 1070 1080
FCLHDINECS SNPCLNAGTC VDGLGTYRCI CPLGYTGKNC QTLVNLCSRS PCKNKGTCVQ
1090 1100 1110 1120 1130 1140
EKARPHCLCP PGWDGAYCDV LNVSCKAAAL QKGVPVEHLC QHSGICINAG NTHHCQCPLG
1150 1160 1170 1180 1190 1200
YTGSYCEEQL DECASNPCQH GATCNDFIGG YRCECVPGYQ GVNCEYEVDE CQNQPCQNGG
1210 1220 1230 1240 1250 1260
TCIDLVNHFK CSCPPGTRGL LCEENIDECA GGPHCLNGGQ CVDRIGGYTC RCLPGFAGER
1270 1280 1290 1300 1310 1320
CEGDINECLS NPCSSEGSLD CVQLKNNYNC ICRSAFTGRH CETFLDVCPQ KPCLNGGTCA
1330 1340 1350 1360 1370 1380
VASNMPDGFI CRCPPGFSGA RCQSSCGQVK CRRGEQCIHT DSGPRCFCLN PKDCESGCAS
1390 1400 1410 1420 1430 1440
NPCQHGGTCY PQRQPPHYSC RCPPSFGGSH CELYTAPTST PPATCQSQYC ADKARDGICD
1450 1460 1470 1480 1490 1500
EACNSHACQW DGGDCSLTME DPWANCTSTL RCWEYINNQC DEQCNTAECL FDNFECQRNS
1510 1520 1530 1540 1550 1560
KTCKYDKYCA DHFKDNHCDQ GCNSEECGWD GLDCASDQPE NLAEGTLIIV VLLPPEQLLQ
1570 1580 1590 1600 1610 1620
DSRSFLRALG TLLHTNLRIK QDSQGALMVY PYFGEKSAAM KKQKMTRRSL PEEQEQEQEV
1630 1640 1650 1660 1670 1680
IGSKIFLEID NRQCVQDSDQ CFKNTDAAAA LLASHAIQGT LSYPLVSVFS ELESPRNAQL
1690 1700 1710 1720 1730 1740
LYLLAVAVVI ILFFILLGVI MAKRKRKHGF LWLPEGFTLR RDSSNHKRRE PVGQDAVGLK
1750 1760 1770 1780 1790 1800
NLSVQVSEAN LIGSGTSEHW VDDEGPQPKK AKAEDEALLS EDDPIDRRPW TQQHLEAADI
1810 1820 1830 1840 1850 1860
RHTPSLALTP PQAEQEVDVL DVNVRGPDGC TPLMLASLRG GSSDLSDEDE DAEDSSANII
1870 1880 1890 1900 1910 1920
TDLVYQGASL QAQTDRTGEM ALHLAARYSR ADAAKRLLDA GADANAQDNM GRCPLHAAVA
1930 1940 1950 1960 1970 1980
ADAQGVFQIL IRNRVTDLDA RMNDGTTPLI LAARLAVEGM VAELINCQAD VNAVDDHGKS
1990 2000 2010 2020 2030 2040
ALHWAAAVNN VEATLLLLKN GANRDMQDNK EETPLFLAAR EGSYEAAKIL LDHFANRDIT
2050 2060 2070 2080 2090 2100
DHMDRLPRDV ARDRMHHDIV RLLDEYNVTP SPPGTVLTSA LSPVLCGPNR SFLSLKHTPM
2110 2120 2130 2140 2150 2160
GKKARRPNTK STMPTSLPNL AKEAKDAKGS RRKKCLNEKV QLSESSVTLS PVDSLESPHT
2170 2180 2190 2200 2210 2220
YVSDATSSPM ITSPGILQAS PTPLLAAAAP AAPVHTQHAL SFSNLHDMQP LAPGASTVLP
2230 2240 2250 2260 2270 2280
SVSQLLSHHH IAPPGSSSAG SLGRLHPVPV PADWMNRVEM NETQYSEMFG MVLAPAEGAH
2290 2300 2310 2320 2330 2340
PGIAAPQSRP PEGKHMSTQR EPLPPIVTFQ LIPKGSIAQA AGAPQTQSSC PPAVAGPLPS
2350 2360 2370 2380 2390 2400
MYQIPEMPRL PSVAFPPTMM PQQEGQVAQT IVPTYHPFPA SVGKYPTPPS QHSYASSNAA
2410 2420 2430 2440 2450 2460
ERTPSHGGHL QGEHPYLTPS PESPDQWSSS SPHSASDWSD VTTSPTPGGG GGGQRGPGTH
2470
MSEPPHSNMQ VYA